TRH Financial’s AbbVie ABBV Stock Holding History

TRH Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$598K	Buy	3,901 +58	+2%	+$8.86K	0.2%	46
2022 Q1	$623K	Buy	3,843 +25	+0.7%	+$3.63K	0.18%	52
2021 Q4	$517K	Buy	3,818 +30	+0.8%	+$3.54K	0.16%	50
2021 Q3	$409K	Sell	3,788 -104	-3%	-$11.9K	0.16%	52
2021 Q2	$438K	Sell	3,892 -1,252	-24%	-$141K	0.19%	52
2021 Q1	$557K	Sell	5,144 -315	-6%	-$33.7K	0.28%	49
2020 Q4	$585K	Sell	5,459 -202	-4%	-$19.4K	0.34%	44
2020 Q3	$496K	Sell	5,661 -811	-13%	-$76.4K	0.33%	43
2020 Q2	$643K	Buy	+6,472	New	+$570K	0.51%	43
2019 Q4	$679K	Buy	+7,641	New	+$634K	0.59%	40

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TRH Financial's ABBV Position: Q2 2022 in Review

TRH Financial increased its AbbVie (ABBV) stake by 1.5% in Q2 2022, buying an estimated $8.86K and bringing the position to 3,901 shares worth $598K. The position accounts for 0.2% of the portfolio, ranked #46.

TRH Financial first reported a position in ABBV in Q4 2019 and has held it in 10 quarters since. The position peaked at $679K in Q4 2019. 3,004 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

TRH Financial held 3,901 shares of AbbVie worth $598K as of Q2 2022.
TRH Financial bought 58 AbbVie shares in Q2 2022, an estimated $8.86K.
AbbVie made up 0.2% of TRH Financial's portfolio in Q2 2022, its #46 holding.
TRH Financial first reported a position in AbbVie in Q4 2019 and has held it in 10 quarters since.
TRH Financial's AbbVie position peaked at $679K in Q4 2019.
3,004 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on TRH Financial's 13F filing for Q2 2022, filed 26 Jul 2022.